Viewing StudyNCT00004175



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004175
Status: COMPLETED
Last Update Posted: 2012-06-06
First Post: 1999-12-10

Brief Title: Docetaxel Doxorubicin and Cyclophosphamide in Treating Women With Stage III Breast Cancer
Sponsor: Northwestern University
Organization: Northwestern University

Organization Data

Organization: Northwestern University
Class: OTHER
Study ID: NU 98B1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Northwestern University
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH